SCIESCOPUSQ2
Expert Review of Anticancer Therapy
TAYLOR & FRANCIS LTD, United Kingdom
Expert Review of Anticancer Therapy is an academic journal published by TAYLOR & FRANCIS LTD (United Kingdom). Identifiers: ISSN 1473-7140, eISSN 1744-8328. Indexed in SCIE, SCOPUS. Metrics: JIF 2.8, CiteScore 5.2, SJR 0.926, SNIP 0.68. Subject areas: ONCOLOGY. tlooto lists 3,685 papers from this journal.
CiteScore
5.20
Scopus citation metric
SJR
0.926
SCImago rank
SNIP
0.68
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1473-7140
- eISSN
- 1744-8328
- Abbreviation
- EXPERT REV ANTICANC
- Publisher
- TAYLOR & FRANCIS LTD
- Country
- United Kingdom
Web of Science categories
SCIEONCOLOGY
Scopus ASJC categories
2730 Oncology2736 Pharmacology (medical)
Keywords
Oncology
Papers in this journal
Recent papers
- The clinical utility of molecular residual disease testing in early-stage breast cancer.
2026
- Expert consensus on the role of immunotherapy in nasopharyngeal carcinoma: clinical and economic perspectives from the GCC region.
2026
- Body composition and physical activity as predictors of immune-related adverse events in patients undergoing cancer immunotherapy: a systematic review.
2026
- Radiotheranostics in solid tumours: focus on radiopharmaceutical therapy and clinical challenges.
2026
- Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials.
2026
Most cited papers
- Current and future therapeutic approaches for osteosarcoma
2018 · 630 citations
- The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care
2018 · 498 citations
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
2011 · 485 citations
- Chemotherapy resistance in osteosarcoma: current challenges and future directions
2006 · 383 citations
- Overview and recent advances in the treatment of neuroblastoma
2017 · 363 citations